General MedicationsINJECTIONStandard
SODIUM TETRADECYL SULFATE
SODIUM TETRADECYL SULFATE
Standard Dose
60MG/2ML (30MG/ML)
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary
Approval overview SODIUM TETRADECYL SULFATE is listed in Drugs@FDA under application 209937 (ANDA).
Review priority: STANDARD Marketing status: Prescription Active ingredient SODIUM TETRADECYL SULFATE Form and strength INJECTABLE;INJECTION - 60MG/2ML (30MG/ML) Sponsor HIKMA Submission history Latest submission status date: 2019-12-09 00:00:00.
Structured Monograph
Clinical summary
Approval overview SODIUM TETRADECYL SULFATE is listed in Drugs@FDA under application 209937 (ANDA). Review priority: STANDARD Marketing status: Prescription Active ingredient SODIUM TETRADECYL SULFATE Form and strength INJECTABLE;INJECTION - 60MG/2ML (30MG/ML) Sponsor HIKMA Submission history Latest submission status date: 2019-12-09 00:00:00. Submission type: ORIG.
Monitoring
- • Marketing status: Prescription
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.